http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13180488

Outgoing Links

Predicate Object
contentType Clinical Trial|Clinical Trial, Phase II|Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't
endingPage 6
issn 0390-6078
issueIdentifier 12
pageRange 1281-6
publicationName Haematologica
startingPage 1281
bibliographicCitation Cervantes F, Sureda A, Hernández-Boluda JC, Martino R, Brunet S, Borrego D, Antich JL, Montserrat E. Interferon alpha plus intermittent oral Ara-C ocfosfate (YNK-01) in chronic myeloid leukemia primarily resistant or with minimal cytogenetic response to interferon. Haematologica. 2001 Dec;86(12):1281–6. PMID: 11726320.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_859bcd08bfd41219edf56c6c6e51f8a9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a40e881af62307453dd008dff2ef961d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbb051a3c74534b8b30e5703c3d0faab
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1325efcdc12e5a93c7332f69662bfb63
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca50792365a5d350efc9c6988f824dbb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2ca6efc2cdae548379cb548dcab7479
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3181743e1ca401b973d044c6703e90b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf8f02feca3406b64c4657ee8c9c2894
date 200112
identifier https://pubmed.ncbi.nlm.nih.gov/11726320
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3942
https://portal.issn.org/resource/ISSN/0390-6078
language English
source https://pubmed.ncbi.nlm.nih.gov/
title Interferon alpha plus intermittent oral Ara-C ocfosfate (YNK-01) in chronic myeloid leukemia primarily resistant or with minimal cytogenetic response to interferon
discusses http://id.nlm.nih.gov/mesh/M0005575
http://id.nlm.nih.gov/mesh/M0025711
http://id.nlm.nih.gov/mesh/M0001643
http://id.nlm.nih.gov/mesh/M0169659
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D015464Q000188
http://id.nlm.nih.gov/mesh/D000971Q000008
http://id.nlm.nih.gov/mesh/D003568Q000031
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D020732
http://id.nlm.nih.gov/mesh/D015464Q000235
http://id.nlm.nih.gov/mesh/D000971Q000633
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D003568Q000008
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D010865
http://id.nlm.nih.gov/mesh/D016898Q000008
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D015464Q000175
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D019008
http://id.nlm.nih.gov/mesh/D001088Q000008
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918130
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7811

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128157154

Total number of triples: 54.